5 курс / Пульмонология и фтизиатрия / Бронхиальная_астма_и_хроническая_обструктивная

128.Ehlenfeldt, M.K. Oxygen radical absorbance capacity (ORAC) and phenolic and anthocyanin concentrations in fruit and leaf tissues of highbush blueberry / M.K. Ehlenfeldt, R.L. Prior // J. of Agricultural. and Food Chemistry. – 2001. – V. 49. – P. 2222–2227.

129.Elevated concentrations of exhaled hydrogen peroxide in asthmatic patients / A. Emelyanov, G. Fedoseev, A. Abulimity et al. // Chest. – 2001. - V.120. – Р. 1136–1139.

130.Elevation of antioxidant enzymes in the clinical effects of radon and thermal therapy for bronchial asthma / F. Mitsunobu, K. Yamaoka, K. Hanamoto et al. // J. Radiat. Res. (Tokyo). - 2003. - V.44, №2. - P. 95-99.

131.Epidemiology and costs of chronic obstructive pulmonary disease / K.R. Chapman, D.M. Mannino, J.B. Soriano et al. // Eur. Respir. J. - 2006. –

V.28, №6. – Р. 1290.

132.Estévez, A.G. Nitric oxide and superoxide, a deadly cocktail / A.G.

Estévez, J. Jordán // Ann. N. Y. Acad. Sci. – 2002. – V.962. – Р.207-211.

133.Estimation of the antioxidant activities of flavonoids from their oxidation potentials / B. Yang, A. Kotani, K. Arai, F. Kusu // Analytical Sciences (Japan). – 2001. – V. 17. – P. 599–604.

134.Evaluation of antioxidative activity of some antioxidants by means of a combined optothermal window and a DPPH free radical colorimetry / M.Buijnsters, D.Bicanic, M.Mihai Chirtoc et al. // Analytical Sciences (Japan).

–2001. – V. 17. – P.s544–s546.

135.Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease / P. Paredi, S.A. Kharitonov, D. Leak et al. // Am. J. Respir. Crit. Care Med. – 2000. – V.162. – Р. 369–373.

136.Exhaled nitric oxide levels during treatment in patients hospitalized with asthma / A.P. Baptist, B. Shah, Y. Wang et al. // Allergy. Asthma. Proc. – 2008. – V.29, №2. – Р. 171-176.

137.Expression of heme oxygenase isoenzymes 1 and 2 in normal and asthmatic airways: effect of inhaled corticosteroids / S. Lim, D. Groneberg, A. Fischer et al. // Am. J. Respir. Crit. Care Med. – 2000. – V.162, №5. – P. 19121918.

138.Fehrenbach, H. Alveolar epithelia type II cell: Defender of the alveolus revisited / H. Fehrenbach // Respir. Res. – 2001. – V.2. – Р. 33-46.

139.Forman, H.J. Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling / H.J. Forman, М. Torres // Am. J. Respir. Crit. Care Med. – 2002. – V.166, №12. – Р. 4-9.

140.Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils / J.P. Eiserich, M. Hristova, C.E. Cross et al. // Nature. – 1998. – V.391. – P. 393-397.

141.Frei, B. Antioxidant defenses and lipid peroxidation in human blood plasma / B. Frei, R. Stocker, B.N. Ames // Proc. Natl. Acad. Sci. USA. – 1988. – V85. – Р. 9748-9752.

100

142.Geller, D.A. Molecular biology of nitric oxide synthases / D.A. Geller, T.R. Billiar // Canc. Metastasis Rev. – 1998. – V. 17. – P. 7.

143.Geographic variation in the prevalence of asthma symptoms in Spanish children and adolescents. International Study of Asthma and Allergies in Childhood (ISAAC) Phase 3, Spain / I. Carvajal-Uruena, L. Garcia-Marcos, R. Busquets-Monge et al. // Arch. Bronconeumol. – 2005. – V.41, №12. – Р. 659 - 666.

144.Gilbert, D.L. Oxygen and living processes: an interdisciplinary approach / D.L. Gilbert – N.Y.: Springer-Verlag, 1981. – 401 p.

145.Gilmour, P.S. Overview of the antioxidant pathways in relation to effects of air pollution / P.S. Gilmour, K. Donaldson, W. MacNee // Eur. Respir. Mon. – 2002. – V.21. - P. 241-261.

146.Global asthma control: возможно ли достижение целей терапии? / Л.М. Огородова, О.С. Кобякова, Ф.И. Петровский и др. // Аллергология. –

2001. – №1. – С. 15-20.

147.Green, R.H. The reclassification of asthma based on subphenotypes / R.H. Green, C.E. Brightling, P. Bradding // Curr. Opin. Allergy Clin. Immunol.

–2007. – V.7. – Р. 43–50.

148.Habib, S.S. Elevated exhaled nitric oxide (NO) in asymptomatic asthmatics taking bronchodilators on demand with controlled body composition / S.S. Habib // J. Pak. Med. Assoc. – 2009. – V.59, №3. – Р. 147-150.

149.Haddad, J.J. A non-hypoxic, ROS-sensitive pathway mediates TNF-α- dependent regulation of HIF-1α / J.J. Haddad, S.C. Land // FEBS Lett. – 2001. – V.505. – Р. 269-274.

150.Haddad, J.J. Oxygen-sensing mechanisms and regulation of redoxresponsive transcription factors in development and pathoahysiology / J.J. Haddad // J. Respir. Res. - 2002. - V.3. - P. 1-27.

151.Haddad, J.J. The ex vivo differential expression of apoptosis signaling cofactors in the developing lung: Essential role of oxygenation during the transition from placental to pulmonary-based respiration / J.J. Haddad, K.K. Choudhary, S.C. Land // Biochem. Biophys. Res. Commun. – 2001. – V.281, №2. – Р. 311-316.

152.Halliwell, B.J. Free radicals in Biology and Medicine. Third edition. / B.J. Halliwell, M.C. Cutteridge – Oxford: Oxford University Press. – 1999. – P. 937.

153.Halliwell, B.J. Reactive species and antioxidants. redox biology is a fundamental theme of aerobic life / B.J. Halliwell // Plant. Physiol. – 2006. – V. 141. – P. 312-322.

154.Harman, D. Aging: A theory based on free radicals and radiation chemistry / D. Harman // J. Gerontol. – 1956. – V. 11. – P. 298-300.

155.Healthcare costs are reduced when asthma is treated with budesonide and formoterolin a single inhaler compared with the same medication via

101

separate inhalers / L. Rosenhall, K. Ericsson, S. Borg, F. Andersson // Eur. Respir. J. – 2001. – V. 18 (Suppl. 33). – P. 54.

156.Heffner, J.A. State of the art: pulmonary strategies of antioxidant defense / J.A. Heffner, J.E. Repine // Am. Rev. Respir. Dis. – 1989. – V.140. – Р.531-554

157.Henricks, P.A. Reactive oxygen species as mediators in asthma / P.A. Henricks, F.P. Nijkamp // Pulm. Pharmacol. Ther. – 2001. – V.14. – Р. 409-420.

158.Higenbottam, T. Lung disease and pulmonary endothelial nitric oxide / T.Higenbottam // Exp. Physiol. – 1995. – V.80, № 5. – P.855-864.

159..High levels of exhaled nitric oxide (NO) and NO synthase III expression in lesional smooth muscle in lymphangioleiomyomatosis / R.A. Dweik, D. Laskowski, M. Ozkan et al. // Am. J. Respir. Cell Mol. Biol. – 2001.

–V.24. – Р.414-418.

160.How exposure to environmental tobacco smoke, outdoor air pollutants, and increased pollen burdens influences the incidence of asthma / M.I. Gilmour, , M.S. Jaakkola, S.J. London et al. // Environ Health Perspect. – 2006. – V. 114, №4. – P. 627-633.

161.Human lung mononuclear cells induce nitric oxide synthase in murine airway epithelial cells in vitro: role of TNFalpha and IL-1beta / R.A. Robbins, J.H. Sisson, D.R. Springall et al. // Am. J. Respir. Crit. Care Med. – 1997. – V. 155. – P. 268.

162.Hu, Y.J. Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium / Y.J. Hu, A.M. Diamond // Cancer Research. – 2003. – V. 63. – P. 3347-3351.

163.Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone / O. Zetterstrom, R. Buhl, H. Mellem et al. // Eur. Respir. J. - 2001. – V. 18, №2. – P. 262-268.

164.Immunohistochemical localisation of inducible nitric oxide syntase and 3 nitrotyrosine in rat liver tumors induced by N-nitroodiethy lamine / B. Ahn, B.S. Han, D.J. Kim, H. Ohshima // Carcinogenesis. – 1999. – V.20, №7. – P. 1337-1344.

165.Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence / R. Gysin, R. Kraftsik, J. Sandell et al. // Proc. Natl. Acad. Sci. USA. – 2007. – V.104, №42. – Р.16621-16626.

166.Increased concentrations of glutathione in induced sputum of patients with mild or moderate allergic asthma / J. Beier, K.M. Beeh, D. Semmler et al. // Ann. Allergy Asthma Immunol. – 2004. – V.92, №4. – Р. 459-463.

167.Increased exhaled nitric oxide in chronic bronchitis: comparison with asthma and COPD / F.M. Delen, J.M. Sippel, M.L. Osborne // Chest. – 2000. – V.117. – Р. 695–701.

168.Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases / M. Corradi, P. Montuschi, L.E. Donnelly et al. / Am. J. Respir. Crit. Care Med. – 2001. – V.163. – Р. 854–858.

102

169.Increased oxidative stress and altered levels of antioxidants in asthma / A. Nadeem, S.K. Chhabra, A. Masood, H.G. Raj // J. Allergy Clin. Immunol. - 2003. - V.111, №1. - P. 72-78.

170.Increase in reactive oxygen metabolite level in acute exacerbations of asthma / S. Suzuki, S.Matsukura, H. Takeuchi et al. // Int. Arch. Allergy. Immunol. – 2008. – V.146, №1. – Р. 67-72.

171.Interferon gamma and interleukin-4 stimulate prolonged expression of inducible nitric oxide synthase in human airway epithelium through synthesis of soluble mediators / F.H. Guo, K. Uetani, S.J. Haque, et al. // J. Clin. Invest. – 1997. –V. 100. – P. 829–838.

172.International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study / A.S.Buist, M.A.McBurnie, W.M.Vollmer // Lancet. – 2007. – V.370, №9589. – P. 741-750.

173.Kolpakova, A. Redox status, metals, microelements and cytokines in blood in bronchial asthma patients / A. Kolpakova, S. Smirnova, S. Kadricheva // Eur. Respir. J.: abstracts 16th ERS Annual Congress – Munich, Germany,

September 2-6, 2006 – V.28, Suppl. 50. – P3937.

174.Kanazawa, H. Nitrogen oxides reduce albuterol-induced bronchodilation in patients with bronchial asthma / H. Kanazawa, K. Hirata, J. Yoshikawa // Respiration/ – 2002. – V.69. – P.490–495.

175.Kaur, B. Vitamin C supplementation for asthma (Cochrane Review) / B. Kaur, B.H. Rowe, F.S. Ram // Cochrane Database Syst. Rev. – 2001. – V.4. – P.CD000993.

176.Kelly, F.J. Oxidative lung injury F.J. Kelly / Eds. A. Tomasi, T.

Özben, V.P. Skulachev // Free radicals, nitric oxide, and inflammation: molecular, biochemical, and clin ical aspects. - 2003. – V. 344. - Р. 237-251.

177.Kharitonov, S.A. Biomarkers of some pulmonary diseases in exhaled breath / S.A. Kharitonov, P.J. Barnes / Biomarkers. – 2002. – V.7. – P.1–32.

178.Kinnula, V.L. Superoxide dismutases in the lung and human lung diseases / V.L.Kinnula, J.D.Crapo // Am. J. Respir. Crit. Care Med. - 2003. - V.167, №12. - P. 1600-1619.

179.Klein, J.A. Oxidative stress, cell cycle, and neurodegeneration / J.A. Klein, S.L. Ackerman // J. Clin. Invest. – 2003. – V. 111. – Р.785-793.

180.Kolpakov, F. BioUML: visual modeling, automated code generation and simulation of biological systems / F. Kolpakov, M. Puzanov, A. Koshukov // Proceedings of The Fifth International Conference on Bioinformatics of Genome Regulation and Structure, 2006, Novosibirsk, Russia. – 2006. – V.3. – P. 281-285.

181.Kolpakova, A.F. Oxidative stress as common mechanism exacerbation

of chronic respiratory diseases induced by air pollution / A.F. Kolpakova, N.G. Maksimov, V.A. Rogov // Eur. Respir. J. Abstracts.14th ERS Annual Congress. Glasgow. UK. – 2004. – P.321.

103

182.Korotkova, E.I. Study of antioxidant properties by voltammetry / E.I. Korotkova, Y.A. Karbainov, A.V. Shevchuk // J. of Electroanalytical Chemistry.

–2002. –V. 518,№1. – P. 56–60.

183.Korshunov, S.S. A potential role for periplasmic superoxide dismutase in blocking the penetration of external superoxide into the cytosol of Gramnegative bacteria / S.S. Korshunov, J.A. Imlay // Mol. Microbiol. – 2002. –

V.43, №1. – Р.95-106.

184.Kurosawa, M. Cu-Zn superoxide dismutase activities in platelets from stable bronchial asthmatic patients / M.Kurosawa, H.Kobayashi, M.Nakano // Int. Arch. Allergy Immunol. - 1993. - V.101, №1. - P. 61-65.

185.Lander, H.M. An essential role for free radicals and derived species in signal transduction / H.M. Lander // FASEB J. – 1997. – V. 11,№ 1. – P. 118– 124.

186.Lipid peroxidation as determined by plasma isoprostanes is related to disease severity in mild asthma / L.G. Wood, D.A. Fitzgerald, P.G. Gibson et al. // Lipids. – 2000. – V.35, №9. – P. 967-974.

187.Long-term repeatability of induced sputum cells and inflammatory markers in stable, moderately severe COPD / K.M. Beeh, J. Beier, O. Kommann et al. // Chest. – 2003. – V.123. – Р. 778-783.

188.MacNee, W. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease / W. MасNee // Proc. Am. Thorac. Soc. – 2005. – V.2. – Р. 50–60.

189.Masoli, M. The global burden of asthma: executive summary of the GINA Dissemination Committee report / М.Masoli, D.Fabian, S.Holt // Allergy.

–2007. – V.62, №3. – Р. 213-215.

190.Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium / J.L. Vanoverschelde, W. Wijns, C.Depre et al. // Circulation. – 1993. – V.87. – P.1513-1523.

191.Meister, A. Glutathione / A. Meister, M.E. Anderson / Annu. Rev. Biochem. – 1983. – V. 52. – P.711–760.

192.Message, S.D. Viruses in asthma / S.D. Message, S.L. Johnston // Br. Med. Bull. – 2002. – V.61. – P. 29–43.

193.Mitochondrial involvement in Alzheimer's disease / E. Bonilla, K. Tanji, M. Hirano et al. // Biochem. et Biophys. Acta. – 1999. – V. 1410. – P. 171-182.

194.Molecular mechanisms of increased nitric oxide (NO) in asthma: evidence for transcriptional and post-translational regulation of NO synthesis / F.H. Guo, S.A. Comhair, S. Zheng et al. // J. Immunol. – 2000. – V.164. – Р.5970-5980.

195.Molecular mechanisms of respiratory virus-induced inflammation / A. Papi, G. Caramori, I.M. Adcock et al. // In: Johnston SL, Papadopoulos NG, eds.

104

Respiratory infections in allergy and asthma. Lung Biology in Health and Disease Series. Volume 178. New York: Marcel Dekker, 2003 – 210–228.

196.Montuschi, P. Exhaled carbon monoxide and nitric oxide in COPD // P.Montuschi, S.A.Kharitonov, P.J.Barnes // Chest. – 2001. – V.120. – Р. 496– 501.

197.Nadeem, A. Increased oxidative stress in acute exacerbations of asthma / A.Nadeem, H.G.Raj, S.K.Chabra // J. Asthma. – 2005. – V.42. – Р.45– 50.

198.Nijkamp, F.P. Nitric oxide and bronchial hyperresponsiveness / F.P.Nijkamp, G.Folkerts // Arch. Int. Pharmacodyn. - 1995. - V.329, №1. - P. 81-96.

199.Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization / L. Kobzik, D.S. Bredt, C.J. Lowenstein et al. // Am.

J.Respir. Cell Mol. Biol. – 1993. – V.9. – Р.371-377.

200.Nitrones, their value as therapeutics and probes to understand aging / R.A. Floyd, K. Hensley, M.J. Forster et al. // Mech. Ageing. – 2002. – V.30123.

– P.1021–1031.

201.O'Reilly, P. Clinical use of exhaled biomarkers in COPD / P.O' Reilly,

W.Bailey // Int. J. Chron. Obstruct. Pulmon. Dis. – 2007. – V.2, №4. – Р. 403408.

202.Owen, C.A. Proteinases and oxidants as targets in the treatment of chronic obstructive pulmonary disease / C.A. Owen // Proc. Am. Thorac. Soc. – 2005. – V.2, №4. – Р. 373-385.

203.Oxidants in the gas phase of cigarette smoke pass through the lung alveolar wall and raise systemic oxidative stress / Y. Yamaguchi, F. Nasu, A. Harada, M. Kunitomo // J. Pharmacol. Sci. – 2007. – V.103. – Р. 275–282.

204.Oxidant stress modulates murine allergic airway responses / M. Talati,

B.Meyrick, R.S. Peebles et al. // Free Radic. Biol. Med. – 2006. – V. 40, №7. –

P.1210-1219.

205.Oxidative stress and acute lung injury / C.Chow, M.T.H. Abreu, T.Suzuki et al. // Am. J. Respir. Cell Mol. Biol. – 2003. – V.29. – Р. 427-431.

206.Oxidative stress in expired breath condensate of patients with COPD /

K.Kostikas, G. Papatheodorou, K. Psathakis et al. / Chest. – 2003. – V.124. – Р. 1373–1380.

207.Oxidative stress status in patients with chronic obstructive pulmonary disease and its relation to glucocorticoid receptor levels / L.Y. Liu, M. Zeng, C.M. Xie et al. // Nan Fang Yi Ke Da Xue Xue Bao. – 2008. – V.28, №6. – Р. 992-996.

208.Oxidized vitamin E and glutathione as markers of clinical status in asthma / L.G. Wood, M.L. Garg, R.J. Blake et al. // Clin. Nutr. – 2008. – V.27, №4. – P.579-586.

209.Passwater, R. Selenium and other antioxidants in reducing cancer incidence / R. Passwater // Cancer: New Direction. American Laboratory. –

105

1973. – V.67. – P.37-45.

210.Pendharkar, S. The clinical significance of exhaled nitric oxide in asthma / S. Pendharkar, S. Mehta // Can. Respir. J. – 2008. – V.15, №2. – Р.99106.

211.Peroxynitrite induces airway hyperresponsiveness in guinea pigs in vitro and in vivo / G.Sadeghi-Hashjin, G.Folkerts, P.A.J.Henricks et al. // Am. J. Respir. Crit. Care Med. - 1996. - V.153. - P. 1697-1701.

212.Polymorphisms and functional activity in superoxide dismutase and catalase genes in smokers with COPD / J.C.W.Mak, S.P.Ho, W.C.Yu et al. // Eur. Respir. J. – 2007. – V.30. – Р. 684-690.

213.Polymorphism in the 5'-flanking region of human glutamate-cysteine ligase modifier subunit gene is associated with myocardial infarction / S. Nakamura, K. Kugiyama, S. Sugiyama et al. // Circulation. – 2002. – V. 105, №25. – Р.2968-2973.

214.Postepski, J. Selected parameters of the oxidative-antioxidative balance in children with bronchial asthma exacerbations / J.Postepski // Pol. Merkuriusz. Lek. - 2001. - V.11, №65. - P. 385-388.

215.Pulmonary biomarkers in chronic obstructive pulmonary disease / P.J. Barnes, B. Chowdhury, S.A. Kharitonov et al. // Am. J. Resp. Crit. Care Med. – 2006. - V.174. – Р. 6-14.

216.Pulmonary toxicology of ultrafine particles / K. Donaldson, D. Brown, A. Clouter et al. //J. Aerosol. Med. –2002 . – V.15,№2. – P.213-220.

217.Quantification of antioxidant activity in brain tissue homogenates using the ‘total equivalent antioxidant capacity’ / T.B. Shea, E. Rogers, D.

Ashline et al. // J. of Neuroscience Methods. – 2003. – V. 125. – P. 55–58.

218.Rahman, I. Oxidant and antioxidant balance in the airways and airway diseases // I. Rahman, S.K Biswas, A. Kode // Eur. J. Pharmacol. – 2006. – V.533, №1-3. – P. 222-239.

219.Rahman, I. Reactive oxygen species. In: Barnes PJ, Drazen J, Rennard S, et al, eds. Asthma and COPD. London: Academic Press, 2002. – P.243–54.

220.Rahman, I. Role of transcription factors in inflammatory lung diseases / I. Rahman, W. MacNee // Thorax. - 1998. - V.53. - P. 601-612.

221.Rapid loss of superoxide dismutase activity during antigen-induced asthmatic response / S.A. Comhair, P.R. Bhathena, R.A. Dweik et al. // Lancet.

– 2000. –V.355. – P.624.

222.Reducing agents inhibit rhinovirus-induced up-regulation of the rhinovirus receptor intercellular adhesion molecule-1 (ICAM-1) in respiratory epithelial cells / A. Papi, N.G. Papadopoulos, L.A. Stanciu et al. // FASEB J. – 2002. – V. 16. – P.1934–1936.

223.Role of CD23 in NO production by human monocytic cells / J.P. Kolb, N. Paul-Eugene Dugas, K. Yamaoka et al. // Res Immunol. – 1995. – V. 146, №9. – P. 684–689.

224.ROS generated by pollen NADPH oxidase provide a signal that

106

augments antigen-induced allergic airway inflammation / I.Boldogh, A.Bacsi, B.K.Choudhury et al. // J. Clin. Invest. – 2005. – V.115. – Р. 2169–2179.

225.Salvemini, D. Therapeutic potential of superoxide dismutase mimetics as therapeutic agents in critical care medicine / D. Salvemini, S. Cuzzocrea // Crit. Care Med. – 2003. – V.31 (suppl 1). – P.S29–38.

226.Singh, S. Nitric oxide, the biological mediator of the decade: fact or fiction? / S. Singh, T.W. Evans // Eur. Respir. J. – 1997. – V.10. – Р.699-707.

227.Selenium serum and urine is associated to mild asthma and atopy. The SUS study / O. Omland, Y. Deguchi, T. Sigsgaard et al. // J. Trace Elem. Med. Biol. – 2002. – V.16. – P.123–127.

228.Semenza, G.L. Oxygen-regulated transcription factors and their role in pulmonary disease / G.L.Semenza // J. Respir. Res. - 2000. - V.1. - P. 159-162.

229.Sen, C.K. Cellular thiols and redox-regulated signal transduction / C.K.Sen // Curr. Top. Cell. Regul. – 2000. – V.36. – Р. 1-30.

230.Serum total antioxidant status in severe exacerbation of asthma: correlation with the severity of the disease / K.Katsoulis, T.Kontakiotis, I.Leonardopoulos et al.// J. Asthma. - 2003. - V.40, №8. - P. 847-854.

231.Shaw, M. The single inhaler for asthma / M. Shaw, W. Jackson // Clinical Vision. - Basel: AstraZeneka, 2001. – P. 1-52.

232.Smirnova, S. The peculiarities of intercellular interactions and

oxidation reduction status according to pathogenic form of bronchial asthma // S. Smirnova, S. Kadricheva, A. Kolpakova // Eur. Respir. J. Abstracts 18TH ERS Annual Congress. Germany, Berlin, October 4-8, 2008. – P.659.

233.Status of lipid peroxidation and plasma iron level in bronchial asthmatic patients / M.K.Narula, G.K.Ahuja, J.Whig et al. // Indian J. Physiol. Pharmacol. – 2007. – V.51, №3. - Р. 289-292.

234.Stephanson, C.J. Antioxidant capability and efficacy of Mega-H silica hydride, an antioxidant dietary supplement, by in vitro cellular analysis using photosensitization and fluorescence detection // C.J. Stephanson, A.M. Stephanson, G.P. Flanagan // J. of Medicinal Food. – 2002. – №5. – P.9–16.

235.Sohal, R.S. Oxidative Stress, Caloric Restriction, and Aging / R.S. Sohal, R. Weindruch // Science. – 1996. – V. 273. – P. 59-63.

236.Superoxidе release and cellular glutathione peroxidase activity in leukocytes from children with persistent asthma / L.E. Marçal, J. Rehder, P.E. Newburger et al. // J. Med. Biol. Res. – 2004. – V.37. – Р.1607–1613.

237.Suzuki, Y.J. Oxidants as stimulators of signal transduction / Y.J. Suzuki, H.J. Forman, A. Sevanian // Free Radical. Biol. Med. – 1997. – V.22,

№1, 2. – Р.269–285.

238.Systemic effect of chronic obstructive pulmonary disease / A.G.N.Agusti, A.Noguera, J.Sauleda et al. // Eur. Respir. J. - 2003. - V.21, №2. - P.347-360.

239.The antioxidative defense in asthma / D.Tekin, B.A.Sin, D.Mungan et al. // J. Asthma. - 2000. - V.37, №1. - P.59-63.

107

240.The cellular composition of induced sputum in chronic obstructive pulmonary disease / R.A.Peleman, P.H.Rytila, J.C.Kips et al. // Eur. Respir. J. – 1999. – V.13. – Р.839-843.

241.The global burden of asthma: executive summary of the GINA Dissemination Committee report / M.Masoli, D.Fabian, S.Holt, R.Beasley // Allergy. – 2004. – V.59, №5. – Р. 469-478.

242.Thiol regulation of pro-inflammatory cytokines reveals a novel immunopharmacological potential of glutathione in the alveolar epithelium / J.J. Haddad, B. Safieh-Garabedian, N.E. Saadé, S.C. Land // J. Pharmacol. Exp. Therap. – 2001. – V. 296. – Р.996-1005.

243.The role of lipid peroxidation and antioxidants in oxidative modification of LDL / H. Esterbauer, J. Gebicki, H. Puhl, G. Jurgens // Free Radic. Biol. Med. – 1992. – V.13. – P. 341-390.

244.The activity of cytochrome oxidase is increased in circulating lymphocytes of patients with chronic obstructive pulmonary disease, asthma, and chronic arthritis / J. Sauleda, F.J. Garcia-Palmer, G. Gonzalez et al. // Am. J. Respir. Crit. Care Med. – 2000. – V. 161. – P. 32-35.

245.Tobin, M.J. Asthma, airway biology, and nasal disorders / M.J. Tobin // Am. J. Respir. Crit. Care Med. – 2003. – V.167, №5. – P. 319-332.

246.Tokimoto, T. Nitric oxide generation in aqueous solutions of cigarette smoke and approaches to its origin / T. Tokimoto, K. Shinagawa // Biol. Chem.

– 2001. – V.382. – P.1613–1619.

247.Tonal nitric oxide and health--a free radical and a scavenger of free radicals / D. Benz, P. Cadet, K. Mantione et al. // Med. Sci. Monit. – 2002. – V.

8, №1. – Р.RA1-4.

248.Use of proteomics to demonstrate a hierarchical oxidative stress response to diesel exhaust particle chemicals in a macrophage cell line / G.G. Xiao, M. Wang, N. Li et al. // J. Biol. Chem. – 2003. – V.278, №50. – P.5078150790.

249.Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD / L.Segura-Valdez, A.Pardo, M. Gaxiola et al. // Chest. - 2000. – V.117. – Р. 684-694.

250.Vural, H. Serum and red blood cell antioxidant status in patients with bronchial asthma / H.Vural, K.Uzun // Can. Respir J. - 2000. - V.7, № 6. - P.476-480.

251.Wood, L.G. Biomarkers of lipid peroxidation, airway inflammation and asthma / L.G.Wood, P.G.Gibson, M.L.Garg // Eur. Respir. J. - 2003. - V.21, №1. – Р. 177-186.

252.Yang, X.F. Fe(II)-EDTA Chelate-Induced Aromatic Hydroxylation of Terephthalate as a New Method for the Evaluation of Hydroxyl RadicalScavenging Ability // X.F. Yang, X.Q. Guo // The Analyst. – 2001. – V.126. – P. 928–932.

108

2.2.Особенности окислительно–восстановительного статуса при 49 бронхиальной астме

2.3.Особенности окислительно–восстановительного статуса при 61 хронической обструктивной болезни легких

109